Thomas Paul Koestler

Thomas Paul Koestler's current jobs include Chairman at Edgemont Pharmaceuticals LLC, Director at Arisaph Pharmaceuticals, Inc., Director at Pearl Therapeutics, Inc., and Director at ImmusanT, Inc. His former jobs include Chairman at Melinta Subsidiary Corp., Vice Chairman at Children's Specialized Hospital, Director-Regulatory Affairs at Bristol Myers Squibb Co., Independent Director at Novo Nordisk A from 2011 to 2016, Independent Director at Momenta Pharmaceuticals, Inc. from 2011 to 2020, Director at Biotechnology Innovation Organization, Senior Director-Drug Regulatory Affairs at Ortho-McNeil Pharmaceutical LLC, Executive Director at Oikos Holdings LLC from 2010 to 2018, Director at ReSearch Pharmaceutical Services, Inc., Director-Regulatory Affairs at Westwood-Squibb Pharmaceuticals, Inc., Independent Director at Melinta Therapeutics, Inc., Manager-Regulatory Affairs & Clinical Safety at Johnson & Johnson, Executive Vice President at Schering-Plough Corp., Executive Vice President at Schering Corp.
from 2003 to 2009, Senior Vice President at Novartis AG, Senior VP & Head-Global Regulatory Affairs at Pharmacia Corp.
in 2003, Senior VP & Global Head-Drug Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 1996 to 2007, Executive Vice President-Global Development at Schering-Plough Research Institute from 2005 to 2006, and Manager-Regulatory Affairs & Clinical Safety at Smithkline & French Laboratories US, Inc. and Sandoz Pharmaceuticals Corp.
He obtained his undergraduate degree from Daemen University in 1975 and his doctorate degree from The State University of New York in 1982.